z-logo
Premium
2,3‐Dihydroxy‐quinoxaline induces ATPase activity of Herpes Simplex Virus thymidine kinase
Author(s) -
Zeifman Alexey A.,
Novikov Fedor N.,
Stroylov Victor S.,
Stroganov Oleg V.,
Chilov Ghermes G.,
Skoblov Alexander Y.,
Miroshnikov Anatoly I.,
Skoblov Yuri S.
Publication year - 2014
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2013.12.017
Subject(s) - quinoxaline , thymidine kinase , herpes simplex virus , chemistry , kinase , phosphorylation , enzyme , virology , hydrolysis , thymidine , ic50 , microbiology and biotechnology , virus , biochemistry , biology , in vitro , organic chemistry
2,3‐Dihydroxy‐quinoxaline, a small molecule that promotes ATPase catalytic activity of Herpes Simplex Virus thymidine kinase (HSV‐TK), was identified by virtual screening. This compound competitively inhibited HSV‐TK catalyzed phosphorylation of acyclovir with K i = 250 μM (95% CI: 106–405 μM) and dose‐dependently increased the rate of the ATP hydrolysis with K M = 112 μM (95% CI: 28–195 μM). The kinetic scheme consistent with this experimental data is proposed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom